Title: TACTI-004: a double-blinded, randomized phase 3 trial in patients with advanced/metastatic non-small cell cancer ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED, savolitinib and surufatinib, will be presented at the ...

Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL The combination of ...

Lung tumours grew when scientists fed mice a "Western diet" high in fat and fructose, a fruit sugar. High-fructose corn syrup ...

TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...

India's first AI-led Incidental Pulmonary Nodule Detection Clinic opens at Thangam Cancer Centre, Tamil Nadu. Part of Project ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

At-home cancer screening kits, particularly those for colon cancer, have gained traction in recent years. “To my knowledge, ...

A groundbreaking artificial intelligence (AI)-driven neural network has been developed to swiftly analyze and interpret ...

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

An openly available generative AI tool can interpret millions of cells in human tissues in hours, revealing new insights and allowing researchers and clinicians to ask questions about conditions such ...